GHK-Cu and growth factors in skincare: what the data actually shows

What did @skinbykristin actually say?

A 38-year-old master aesthetician walked viewers through a nightly serum routine totaling roughly $1,000, built around exosomes, growth factors, and stem cell-derived ingredients. Her core argument: "stem cells, growth factors, exosomes... that is what I saw the biggest difference in my skin." She described an exosome serum as something that "talks to the cells," framed growth factor products as "at home PRP," and said stem cell conditioned media is your "barrier best friend." She also mentioned an OS1 peptide eye product. Her claim was not that these are essential for everyone, but that if you're "super serious about aging," integrating even one could produce visible results. She was transparent that this is her professional research, not a prescription for viewers.

Does the science back this up?

Partially, and the devil is in the details. Growth factors applied topically do have a real evidence base, though it's not as clean as aestheticians often suggest. Exosomes are genuinely promising but largely unproven in the topical skincare context. Stem cell conditioned media is a mixed bag depending on the source.

On growth factors: a randomized controlled trial by Gold et al. (2007, Journal of Drugs in Dermatology) found that topical growth factor preparations improved fine lines and skin texture after 60 days. A later study by Mehta et al. (2019, Journal of Cosmetic Dermatology) confirmed improvements in photoaged skin. The catch is that growth factors are large molecules, and dermal penetration through intact skin is debated. Whether they're acting on fibroblasts in the dermis or primarily at the epidermal surface is not settled.

On exosomes: this is where the hype outruns the data. Most robust exosome research involves injected or topically applied post-procedure exosomes, not off-the-shelf serums. A review by Gurung et al. (2021, Acta Biomaterialia) noted exosomes show real regenerative potential, but standardization and stability of commercial exosome products is a known problem. Calling a serum "regeneration of the skin" is a significant overstatement of what peer-reviewed data currently supports for retail products.

On stem cell conditioned media: the ingredient is real. Plant-derived stem cell extracts, however, do not behave like human stem cell derivatives, and many products blur this line. Human adipose or bone marrow conditioned media products have more relevant data, but it's still early-stage for topical use (Jeong et al., 2021, International Journal of Molecular Sciences).

What did they get wrong (or right)?

She got credit for nuance most influencers skip. She said you do not need all of these, acknowledged the cost is excessive, and framed her routine as professional research. That's more honest than most $1,000 routine videos on the platform.

Where she oversold: comparing growth factor serums to "at home PRP" is misleading. PRP works because platelet-derived growth factors are delivered at wound-healing concentrations directly into tissue. A retail serum sitting on top of intact skin is not a comparable delivery mechanism. This is a feel-good analogy, not a biochemical equivalence.

The "talks to the cells" framing for exosomes is scientifically adjacent to accurate, since exosomes are signaling vesicles by nature, but retail exosome products are not verified to deliver intact, bioactive exosomes in a stable form. The claim that they produce "regeneration of the skin" from a topical serum applied nightly has no controlled clinical evidence behind it at the retail product level.

She also mentioned an OS1 peptide, which appears to refer to a proprietary oligopeptide. Without published independent data on this specific sequence, calling it "revolutionary" is a brand claim, not a science claim.

What should you actually know?

If you're interested in this category of ingredients, the honest answer is that growth factors have the strongest topical evidence of anything she mentioned, and they are worth considering in a serious anti-aging routine. The evidence for topical exosomes in commercial serums, specifically, is not there yet, even if the underlying biology is interesting.

GHK-Cu, a copper peptide not mentioned by name here but relevant to this peptide category, has considerably more published data supporting collagen synthesis and skin repair than most of the products shown (Pickart et al., 2015, Journal of Aging Science). It's also a fraction of the price.

Barrier-supporting ingredients like ceramides, fatty acids, and cholesterol have decades of robust evidence behind them. If your skin has barrier issues, those ingredients, at drugstore prices, will outperform a $200 exosome serum in head-to-head clinical trials simply because the trials exist for the former and largely don't for the latter. Spending $1,000 on serums is a personal choice, not a clinical recommendation. Anyone selling it as the latter is overselling the current evidence.